Peter Wolf Selected Research

Methoxsalen (Oxsoralen)

6/2018	8-Methoxypsoralen Plus Ultraviolet A Reduces the Psoriatic Response to Imiquimod in a Murine Model.
11/2012	Retrospective long-term follow-up in patients with chronic palmoplantar dermatoses after good response to bath PUVA therapy.
3/2012	8-Methoxypsoralen plus UVA treatment increases the proportion of CLA+ CD25+ CD4+ T cells in lymph nodes of K5.hTGFβ1 transgenic mice.
6/2010	8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Wolf Research Topics

Disease

40	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2021 - 04/2003
21	Epilepsy (Aura) 04/2021 - 01/2002
15	Neoplasms (Cancer) 01/2022 - 01/2004
15	Inflammation (Inflammations) 01/2021 - 09/2006
14	Seizures (Absence Seizure) 01/2020 - 01/2002
13	Temporal Lobe Epilepsy 01/2022 - 09/2015
13	Insulin Resistance 12/2021 - 01/2012
10	Obesity 01/2022 - 01/2012
8	Skin Diseases (Skin Disease) 01/2021 - 01/2004
8	Atopic Dermatitis (Atopic Eczema) 01/2021 - 02/2003
7	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 09/2006
5	Hippocampal Sclerosis 01/2021 - 09/2015
4	Skin Neoplasms (Skin Cancer) 04/2022 - 04/2003
4	COVID-19 01/2022 - 01/2021
4	Diabetes Mellitus 01/2022 - 01/2012
4	Mental Disorders (Mental Disorder) 01/2022 - 01/2017
4	Sunburn 01/2022 - 10/2004
4	Weight Loss (Weight Reduction) 10/2021 - 01/2012
4	Hypothyroidism 01/2021 - 01/2012
4	Body Weight (Weight, Body) 10/2020 - 11/2014
4	Mycosis Fungoides 01/2020 - 01/2016
4	Stroke (Strokes) 01/2017 - 06/2011
4	Basal Cell Carcinoma (Rodent Ulcer) 09/2008 - 01/2004
3	Prediabetic State (Prediabetes) 01/2022 - 01/2021
3	Morbid Obesity 01/2022 - 05/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2012
3	Acromegaly 01/2021 - 11/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 06/2020
3	Infections 01/2021 - 01/2004
3	Non-alcoholic Fatty Liver Disease 01/2020 - 07/2014
3	Hyperglycemia 03/2019 - 11/2014
3	Hypersensitivity (Allergy) 03/2018 - 01/2009
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2017 - 08/2011
2	Erythema 04/2022 - 11/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 02/2011
2	Craniopharyngioma (Craniopharyngiomas) 10/2021 - 05/2016
2	Hyperthyroidism 10/2021 - 12/2020
2	Arthritis (Polyarthritis) 03/2021 - 01/2021
2	Vitiligo 01/2021 - 01/2018
2	Alopecia Areata 01/2021 - 01/2003
2	Glucose Intolerance 01/2021 - 01/2014
2	Sudden Unexpected Death in Epilepsy 01/2021 - 01/2020
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021 - 10/2020
2	Heart Failure 10/2019 - 01/2016
2	Addison Disease (Addison's Disease) 07/2019 - 01/2019
2	Dyslipidemias (Dyslipidemia) 02/2019 - 11/2014
2	Generalized Epilepsy 02/2019 - 01/2002
2	Drug Resistant Epilepsy 06/2018 - 12/2002

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
17	LipidsIBA 11/2021 - 01/2012
11	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2012
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2012
10	CytokinesIBA 01/2021 - 09/2009
9	Ficusin (Psoralen)IBA 01/2020 - 04/2003
7	Insulin (Novolin)FDA Link 01/2021 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2012
7	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2002
7	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2014 - 01/2004
5	Sunscreening Agents (Sunscreens)IBA 04/2022 - 11/2003
5	Biological ProductsIBA 01/2021 - 01/2005
5	HDL LipoproteinsIBA 01/2021 - 03/2014
5	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021 - 09/2015
5	DNA (Deoxyribonucleic Acid)IBA 10/2010 - 04/2003
4	Interleukin-17 (Interleukin 17)IBA 07/2019 - 02/2011
4	Immunoglobulin E (IgE)IBA 02/2019 - 08/2011
4	Methoxsalen (Oxsoralen)FDA Link 06/2018 - 06/2010
3	Anthralin (Dithranol)IBA 01/2021 - 11/2015
3	CholesterolIBA 01/2021 - 08/2012
3	Adenosine Triphosphate (ATP)IBA 12/2020 - 07/2014
3	Imiquimod (Aldara)FDA LinkGeneric 01/2020 - 10/2017
3	Carbamazepine (Tegretol)FDA LinkGeneric 02/2019 - 09/2004
3	Valproic Acid (Depakote)FDA LinkGeneric 02/2019 - 10/2005
3	EnzymesIBA 01/2018 - 09/2008
3	Hormones (Hormone)IBA 05/2017 - 01/2012
3	Therapeutic UsesIBA 01/2013 - 01/2009
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021 - 03/2019
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2021 - 05/2017
2	Thyroid HormonesIBA 10/2021 - 05/2017
2	Aryldialkylphosphatase (Paraoxonase)IBA 01/2021 - 10/2014
2	Adenosine Monophosphate (AMP)IBA 01/2021 - 03/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2013
2	Growth Hormone (Somatotropin)IBA 01/2021 - 05/2017
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 11/2020 - 12/2016
2	Vitamin D FDA LinkGeneric 10/2020 - 05/2014
2	MineralocorticoidsIBA 07/2019 - 01/2019
2	GlucocorticoidsIBA 07/2019 - 01/2019
2	Phenobarbital (Luminal)FDA Link 02/2019 - 09/2004
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2019 - 12/2002
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 06/2018
2	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2018 - 12/2016

Therapy/Procedure

22	Therapeutics 10/2021 - 11/2006
12	Photochemotherapy (Photodynamic Therapy) 11/2020 - 01/2004
10	Phototherapy (Light Therapy) 01/2022 - 02/2003
4	Bariatric Surgery 01/2022 - 10/2020
2	Radiotherapy 12/2021 - 05/2016
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2021 - 05/2016
2	Anterior Temporal Lobectomy 01/2021 - 01/2017
2	Aftercare (After-Treatment) 12/2020 - 10/2020
2	Vagus Nerve Stimulation 01/2019 - 01/2005